North America Therapeutic Vaccines Market By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

North America Therapeutic Vaccines Market By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 73 | Pages: 140 | April 2018 | Region: North America


The North America Therapeutic Vaccines Market is set to reach $3335.73 Million by 2023 from $872.27 Million in 2018 with a CAGR of 30.77%. Therapeutics vaccines are useful tools that help in treating a disease by strengthening the patient’s immune system.

Currently, in pipeline several approaches are being developed in order to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. With USA and Canada averaging around 300 people diagnosed per 100,000 the need for therapeutic vaccines became imminent in the region. The field of cancer immunotherapy received an important boost with the FDA’s approval of the first therapeutic cancer vaccine, which surely results in the positive growth of the market.

The vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features which increase the complexity of assessing and understanding pricing and procurement in their context.

Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.

The North America Therapeutic Vaccines Market is segmented by the type of disease into Autoimmune Disease Vaccines (Type I Diabetes), Cancer Vaccines (Multikine, PR1 Peptide Vaccine, TroVax, CYT004-MelQbG10 etc.), Neurological Disease Vaccines (ACC-001, CAD106, Parkinson’s Disease Vaccine, Alzheimer's Disease and Other Disease Vaccines), and Infectious Disease Vaccines (Hepatitis C, HIV/AIDS and Other Infectious Disease Vaccines). Furthermore, on the basis of geography, the North America market is analysed under various regions namely, USA and Canada. North America accounts for the large portion of revenue in the therapeutic vaccine market. The growth of this market will be boosted owing to the presence of advanced and active R&D establishments in the region.

Some of the key players influencing the North America preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                           

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                      

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 By Disease Type                                       

                                5.1.1 Autoimmune Disease Vaccines                      

                                5.1.2 Cancer Vaccines                    

                                                5.1.2.1 Multikine             

                                                5.1.2.2 PR1 Peptide        

                                                5.1.2.3 TroVax  

                                                5.1.2.4 CYT004-MelQbG10           

                                5.1.3 Neurological Disease Vaccines                        

                                                5.1.3.1 ACC- 001               

                                                5.1.3.2 CAD 106

                                                5.1.3.3 Parkinson's Disease Vaccine        

                                                5.1.3.4 Alzheimer's Disease        

                                5.1.4 Infectious Disease Vaccines                             

                                                5.1.4.1 Hepatitis C           

                                                5.1.4.2 HIV/AIDS              

                                                5.1.4.3 Other Infectious Disease               

  1. Geographical Analysis

                6.1 Introduction                                               

                6.2 United States                                            

                6.3 Canada                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 GlaxoSMithKline plc.                                              

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck and Company                                              

                8.3 Bavarian Nordic                                        

                8.4 CSL Limited                                 

                8.5 Emergent Biosolutions Inc.                                  

                8.6 Novartis AG                                

                8.7 Johnson and Johnson                                            

                8.8 MedImmune LLC                                     

                8.9 Pfizer Inc.                                    

                8.10 Sanofi Pasteur                                        

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

     Appendix                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Therapeutic Vaccines Market By Region, From 2018-2023 ( USD Billion )
  2. North America Therapeutic Vaccines Market By Disease Type, From 2018-2023 ( USD Billion )
  3. North America Autoimmune Disease Vaccines Market By Region, From 2018-2023 ( USD Billion )
  4. North America Cancer Vaccines Market By Region, From 2018-2023 ( USD Billion )
  5. North America Neurological Disease Vaccines Market By Region, From 2018-2023 ( USD Billion )
  6. North America Infectious Disease Vaccines Market By Region, From 2018-2023 ( USD Billion )
  7. North America Cancer Vaccines Market By Type, From 2018-2023 ( USD Billion )
  8. North America Multikine Market By Region, From 2018-2023 ( USD Billion )
  9. North America PR1 Peptide Market By Region, From 2018-2023 ( USD Billion )
  10. North America TroVax Market By Region, From 2018-2023 ( USD Billion )
  11. North America CYT004-MelQbG10 Market By Region, From 2018-2023 ( USD Billion )
  12. North America Neurological Disease Vaccines Market By Type, From 2018-2023 ( USD Billion )
  13. North America ACC- 001 Market By Region, From 2018-2023 ( USD Billion )
  14. North America CAD 106 Market By Region, From 2018-2023 ( USD Billion )
  15. North America Parkinson's Vaccine Market By Region, From 2018-2023 ( USD Billion )
  16. North America Alzheimer's Vaccine Market By Region, From 2018-2023 ( USD Billion )
  17. North America Infectious Disease Vaccines Market By Type, From 2018-2023 ( USD Billion )
  18. North America Hepatitis C Vaccines Market By Region, From 2018-2023 ( USD Billion )
  19. North America HIV/AIDS Vaccines Market By Region, From 2018-2023 ( USD Billion )
  20. North America Other Infectious Disease Vaccines Market By Region, From 2018-2023 ( USD Billion )
  21. United States Therapeutic Vaccines Market By Disease Type, From 2018-2023 ( USD Billion )
  22. Canada Therapeutic Vaccines Market By Disease Type, From 2018-2023 ( USD Billion )
  23. United States Cancer Vaccines Market By Type, From 2018-2023 ( USD Billion )
  24. Canada Cancer Vaccines Market By Type, From 2018-2023 ( USD Billion )
  25. United States Neurological Disease Vaccines Market By Type, From 2018-2023 ( USD Billion )
  26. Canada Neurological Disease Vaccines Market By Type, From 2018-2023 ( USD Billion )
  27. United States Infectious Disease Vaccines Market By Type, From 2018-2023 ( USD Billion )
  28. Canada Infectious Disease Vaccines Market By Type, From 2018-2023 ( USD Billion )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.